Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma.

about

Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma.

Item

http://www.wikidata.org/entity/Q48309176

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@en

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@nl

type

Item

label

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@en

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@nl

prefLabel

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@en

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@nl

P1476

Concurrent paclitaxel, capecit ...... squamous cell anal carcinoma.

@en

P2093

Nataliya S Besova

http://www.w3.org/2001/XMLSchema#string

Valeriya V Glebovskaya

http://www.w3.org/2001/XMLSchema#string

Vera A Gorbounova

http://www.w3.org/2001/XMLSchema#string

Yulia E Surayeva

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma.

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma.

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.

Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.

P2888

s00280-017-3408-4

P304

623-629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3408-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28766008

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy